Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02500693Completed
Open-label, single-arm trial, sponsored by Centre Hospitalier Universitaire de Nice. Primary endpoint: Rate of detection of circulating tumor cells in patients who will have a LC detected during the study at 3 years. Started Oct 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02500693.